To this end we analyzed a dataset including tumor expression profiles and clinical data of 1809 breast cancer patients [50] and compared two subsets of patients: those with lowest and highest expression values for ANG-2, PIGF and CD14 (as TEM marker), using as threshold the first and fourth quartile respectively. This evidence concerns the gene PIGF and breast carcinoma.